Experts share insight on the evolving treatment armamentarium for myeloproliferative neoplasms.
EP. 1: A Brief Overview of Myeloproliferative Neoplasms
EP. 2: Making a Differential Diagnosis of Polycythemia Vera
EP. 3: Treatment Armamentarium for Polycythemia Vera
EP. 4: Polycythemia Vera: Ruxolitinib Use and Goals of Therapy
EP. 5: Making a Differential Diagnosis of Myelofibrosis
EP. 6: Addressing the Challenges in Diagnosing MF
EP. 7: Risk Assessment and Staging of Myelofibrosis
EP. 8: Myelofibrosis: Observation and Triggers to Initiate Therapy
EP. 9: Factors in Selecting Therapy for Myelofibrosis
EP. 10: Historical Approaches to the Management of MF
EP. 11: Use of Ruxolitinib in Myelofibrosis
EP. 12: Myelofibrosis: Use of Fedratinib and Pacritinib Therapy
EP. 13: Selection and Management of JAK Inhibitor Therapy in MF
EP. 14: Myelofibrosis: Patient Monitoring and Triggers to Change Therapy
EP. 15: Novel Agents in the Pipeline for Myelofibrosis
EP. 16: Myelofibrosis: Novel Combination Strategies
EP. 17: Clinical Pearls for the Management of Myelofibrosis
Dr Ganesan on the Use of ctDNA Assays For MRD Detection in Cancer Care
Dr Habib on Developments in Palliative Care For Patients With Cancer
Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC
Dr In on the Increased Incidence of Gastric Cancer in Minority Patient Populations